LivaNova PLC (LIVN) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for LivaNova PLC (LIVN:NASDAQ), powered by AI.

Current Price
$64.58
P/E Ratio
55.4
Market Cap
3.5B
Sector
Healthcare
What is the LivaNova PLC stock price forecast?

LivaNova PLC is currently trading at $64.58. View real-time AI analysis on Alpha Lenz.

What is LivaNova PLC insider trading activity?

View the latest insider trading data for LivaNova PLC on Alpha Lenz.

What is LivaNova PLC's P/E ratio?

LivaNova PLC's P/E ratio is 55.4.

LivaNova PLC

NASDAQ · LIVN
$64.58
Ask about LivaNova PLC's future dividend policy...
Alpha Chat Insight

LivaNova PLC trades at a P/E of 55.4 (premium valuation) with modest ROE of 4.9%.

Ask for details

Company Overview

LivaNova PLC is a global medical technology company that focuses on developing and delivering innovative medical devices for cardiac surgery and neuromodulation. With its headquarters situated in London, the company operates at the forefront of the healthcare sector, enhancing patient outcomes through technologically advanced solutions. Notably, LivaNova is renowned for its expertise in cardiopulmonary and heart valve systems essential for intricate cardiac procedures, as well as its impactful neurologic therapeutic devices for treating epilepsy and depression. The firm’s neuromodulation division is pivotal within the medical device industry, highlighting its commitment to tackling chronic neurological conditions with precision and care. As a pacemaker in health innovation, LivaNova contributes significantly to the global healthcare market by providing vital technologies that significantly improve the quality of life for patients around the world. Through a robust network that includes hospitals, clinics, and healthcare professionals, LivaNova maintains its role as a crucial player in advancing medical technology and patient healthcare solutions.

CEOMr. Vladimir A. Makatsaria
SectorHealthcare
IndustryMedical Devices
Employees2,900

Company Statistics

FY 2024

Profile

$3.50BMarket Cap
$1.25BRevenue
0.00Shares Out
2,900Employees

Margins

69.48%Gross
16.86%EBITDA
10.30%Operating
7.05%Pre-Tax
5.04%Net

Valuation

55.35P/E
2.65P/B
2.79EV/Sales
17.74EV/EBITDA
25.75P/FCF

Growth (CAGR)

6.58%Rev 3Yr
2.94%Rev 5Yr
N/AOp Inc 3Yr
57.35%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

2.56%ROA
4.87%ROE
6.13%ROIC

Financial Health

$428.86MCash & Cash Equivalents
$757.27MNet Debt
89.84%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

LivaNova PLC (ticker: LIVN) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 2,900 employees. Market cap is $3.5B.

The current price is $64.58 with a P/E ratio of 55.35x and P/B of 2.65x.

ROE is 4.87% and operating margin is 10.30%. Annual revenue is $1.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
LivaNova PLC (Healthcare) Stock Forecast & Analysis $64.58 | Alpha Lenz